iCubate
Business Services · Alabama, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
601 Genome Way Ste 3005, Huntsville, Ala...Phone Number
(855) 256-3330Website
www.icubate.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About iCubate
iCubate specializes in rapid syndromic testing solutions for infectious diseases, offering a comprehensive molecular diagnostics platform. Their product lineup includes FDA-cleared assays for various pathogens, including COVID-19, and they are committed to making testing accessible for all laboratories. The company aims to enhance diagnostic capabilities through innovative technology and a robust pipeline of assays. iCubate's intended clients include healthcare facilities and laboratories seeking efficient and reliable testing solutions.Explore more
iCubate Org Chart
Get the full picture
Sign in to uncover key details.
MU
Laboratory Technician
HL
Assay Developer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is iCubate your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if iCubate had a recent Job posting/layoffs
Earning: See what the market has to say on iCubate recently announced quarterly report
Funding: Get notified immidiatlly once iCubate has new funding data
iCubate, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when iCubate launches new products
Website visits: Recent activity has been detected on your website
Check out if iCubate is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at iCubate
Check if iCubate has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined iCubate as Masked Content
Find 2 more new buyers
Compare Similar Companies to iCubate
Compare insights from companies similar to iCubate, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
iCubate is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
iCubate is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about iCubate.
iCubate financials insights
Gather financial insights about iCubate, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$161K
iCubate Tech Stack
A closer look at the technologies used by iCubate
See more technologies
Most Recent Scoops
Award
Award
Funding
iCubate has received an SBA PPP loan in the amount of $161,941 from ServisFirst Bank resulting in the retention of 17 jobs.
Funding
iCubate has received an SBA PPP loan for $150,000-350,000 from ServisFirst Bank, supporting the retention of 17 jobs.
Funding
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding iCubate
Sign Up For FreeTo access detailed company insights
iCubate specializes in rapid syndromic testing solutions for infectious diseases, offering a comprehensive molecular diagnostics platform. Their product lineup includes FDA-cleared assays for various pathogens, including COVID-19, and they are committed to making testing accessible for all laboratories. The company aims to enhance diagnostic capabi... Read More
